Loading provider…
Loading provider…
Hematology & Oncology Physician in Miami, FL
NPI: 1114138534Primary Employer
UMiami Medicine - Hematology
doctors.umiamihealth.org
HQ Phone
Get MEDICAL ONCOLOGIST Carmen's Phone Numberphone_androidMobile
Get MEDICAL ONCOLOGIST Carmen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2008 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
University of Miami/Jackson Health System
Fellowship • Hematology and Medical Oncology
2005 - 2008
Residency • Internal Medicine
2001 - 2004
University of Tirgu-Mures Faculty of Medicine
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 235 | 455 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 29 | 52 |
Authors: Elizabeth Mittendorf, Winston Tan, Donald Northfelt, Edith Perez, Mark Pegram, Raphael Clynes
Publication Date: 2016-04-20
Authors: Pamela Crilley, Ricardo Alvarez, Tareq Al Baghdadi, Timothy Cannon, Theodore Pollock, Richard Schilsky, Ramya Thota, David Tait
Journal: Target Oncol
Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia.
Authors: Janet Davis, Phillip Ruiz, Izidore Lossos
Journal: Am J Ophthalmol
Lead Sponsor: Academic and Community Cancer Research United
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Cyclophosphamide, OTHER: Placebo Administration, BIOLOGICAL: Sargramostim, BIOLOGICAL: Multi-epitope Folate Receptor Alpha Peptide Vaccine
Lead Sponsor: Celldex Therapeutics
Intervention / Treatment: DRUG: Capecitabine, DRUG: CDX-011